Women's Health

Venus 2 Study

Vulvovaginal Atrophy

Want to learn about
our experience
in this therapeutic area?

Contact us today.


More than 30 million postmenopausal women experience physical and emotional discomfort due to vulvovaginal atrophy (VVA). Our challenge was to highlight the condition in an open yet sensitive manner in order to randomize 454 postmenopausal women across 60 sites within a five-month period. Based on our successful recruitment campaign for the original Venus Study, we focused our efforts on women between the ages of 40 and 64.


We launched a centralized recruitment campaign that included site tools, brochures, an educational website, online and social media advertising, and WebMD sponsorships. Our campaign drove nearly 160,000 unique visitors to the website and more than 2,700 inquiries to the centralized recruitment center. In the end, we directly referred 25% of all screened patients and 23% of randomized patients. Our efforts saved more than one month of recruitment time and delivered more than a $980,000 return on investment to the sponsor.

At a Glance